Veracyte | VCYT - Current Liabilities

Stock Price
35.25
Daily Change
-0.38 -1.07%
Monthly
-13.11%
Yearly
-10.44%
Q1 Forecast
34.53

Veracyte reported $72.15M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Agenus USD 287.13M 52.57M Sep/2025
Agilent USD 2.35B 455M Sep/2025
Anika Therapeutics USD 19.09M 3.01M Sep/2025
Arrowhead Research USD 347.42M 151.94M Dec/2025
Bruker USD 1.28B 11.1M Dec/2025
Exact Sciences USD 641.15M 56.89M Dec/2025
Heron Therapeutics USD 89.71M 168.89M Sep/2025
Illumina USD 1.59B 377M Dec/2025
Intrexon USD 23.02M 38K Jun/2024
Karyopharm Therapeutics USD 87.16M 12.06M Sep/2025
Laboratory Of America USD 2.82B 194.3M Dec/2025
Ligand Pharmaceuticals USD 30.54M 34.2M Sep/2025
Myriad Genetics USD 148M 51.9M Sep/2025
Rigel Pharmaceuticals USD 94.4M 7.76M Sep/2025
Roche Holding CHF 28B 421M Dec/2025
Sangamo BioSciences USD 47.66M 1.9M Jun/2025
Siemens EUR 49.35B 2.09B Dec/2025
Sonic Healthcare AUD 2.23B 92.84M Dec/2024
Thermo Fisher Scientific USD 15.19B 301M Dec/2025
Veracyte USD 72.15M 4.28M Sep/2025
Waters USD 1.24B 11.8M Dec/2025